Principal Financial Group
ABCL icon

Principal Financial Group’s AbCellera Biologics ABCL Stock Holding History

Principal Financial Group’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,204
Closed -$155K – 2362
2024
Q1 		$155K Sell
34,204
-76,984
-69% -$393K ﹤0.01% 2213
2023
Q4 		$635K Buy
111,188
+18,217
+20% +$84.4K ﹤0.01% 1908
2023
Q3 		$428K Buy
92,971
+20,450
+28% +$124K ﹤0.01% 1983
2023
Q2 		$468K Buy
72,521
+24,473
+51% +$167K ﹤0.01% 1971
2023
Q1 		$362K Sell
48,048
-983
-2% -$8.93K ﹤0.01% 2046
2022
Q4 		$497K Buy
49,031
+23,906
+95% +$276K ﹤0.01% 1977
2022
Q3 		$248K Buy
25,125
+5,222
+26% +$57.3K ﹤0.01% 2146
2022
Q2 		$212K Buy
+19,903
New +$169K ﹤0.01% 2286

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return